VANGUARD GROUP INC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$35,790,966
-7.3%
3,924,448
+7.5%
0.00%0.0%
Q2 2023$38,609,329
-9.4%
3,649,275
+4.8%
0.00%0.0%
Q1 2023$42,599,781
+0.8%
3,483,220
+2.3%
0.00%0.0%
Q4 2022$42,258,148
-6.0%
3,405,169
+3.5%
0.00%0.0%
Q3 2022$44,944,000
-26.5%
3,290,201
-1.3%
0.00%
-50.0%
Q2 2022$61,117,000
+14.1%
3,334,266
+0.1%
0.00%
+100.0%
Q1 2022$53,553,000
+16.8%
3,330,346
+1.7%
0.00%0.0%
Q4 2021$45,832,000
-25.0%
3,273,708
+0.3%
0.00%
-50.0%
Q3 2021$61,144,000
-10.6%
3,264,465
-0.4%
0.00%0.0%
Q2 2021$68,360,000
-27.3%
3,278,650
-1.5%
0.00%
-33.3%
Q1 2021$94,094,000
-10.9%
3,328,408
+3.0%
0.00%0.0%
Q4 2020$105,587,000
+29.0%
3,232,932
+21.0%
0.00%0.0%
Q3 2020$81,867,000
+88.1%
2,671,874
+0.0%
0.00%
+50.0%
Q2 2020$43,531,000
+102.6%
2,670,555
+23.6%
0.00%
+100.0%
Q1 2020$21,491,000
-27.2%
2,159,925
+0.6%
0.00%0.0%
Q4 2019$29,536,000
-8.4%
2,148,002
+1.1%
0.00%0.0%
Q3 2019$32,237,000
-18.7%
2,125,069
+5.6%
0.00%0.0%
Q2 2019$39,628,000
+46.0%
2,012,548
+23.0%
0.00%0.0%
Q1 2019$27,147,000
+25.3%
1,636,376
+6.0%
0.00%0.0%
Q4 2018$21,673,000
-14.9%
1,543,629
+6.0%
0.00%0.0%
Q3 2018$25,477,000
-1.8%
1,455,818
+2.1%
0.00%0.0%
Q2 2018$25,954,000
+11.1%
1,426,033
+14.4%
0.00%0.0%
Q1 2018$23,364,000
+40.4%
1,246,086
+14.6%
0.00%0.0%
Q4 2017$16,640,000
+13.0%
1,087,571
+10.4%
0.00%0.0%
Q3 2017$14,723,000
+264.9%
984,776
+127.0%
0.00%
Q2 2017$4,035,000
+19.4%
433,868
+13.0%
0.00%
Q1 2017$3,378,000
+52.6%
383,835
+2.3%
0.00%
Q4 2016$2,214,000
-5.0%
375,216
+0.6%
0.00%
Q3 2016$2,330,000
+192.3%
372,916
+26.8%
0.00%
Q2 2016$797,000
-33.1%
294,1660.0%0.00%
Q1 2016$1,191,000
-37.2%
294,166
+30.4%
0.00%
Q4 2015$1,896,000225,6670.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders